Our goal is to remain competitive and position the company to maintain exposure to the rewards that will come from having uncommitted, low-cost supply to deliver into a strengthening market.

— Tim Gitzel, President and CEO

 

 Average realized priceCost of purchased and produced uranium (non-IFRS, see pg 41 of MD&A)
201654.4633.69
201746.8028.90
Financial
Results
Expense
Reduction
ANNUAL REVENUE
($ millions)
 Annual Revenue
20172157
20162431
20152754
GROSS PROFIT
($ millions)
 Gross Profit
2017436
2016463
2015697
URANIUM REVENUE
($ millions)
 Uranium Revenue
20171574
20161718
20151866
CAPITAL EXPENDITURES
($ millions)
 2016 Actual2017 Actual2018 Outlook*(2018 Outlook Range)
Capital Expenditures2171431140
DIRECT ADMINISTRATION COSTS
($ millions)
 2016 Actual2017 Actual2018 Outlook*(2018 Outlook Range)
Direct Administration Costs19515112010

2016 Actual 2017 Actual 2018 Outlook* (2018 Outlook Range)

* Includes our share of Inkai capital.

The information regarding currently expected capital expenditures for future periods is forward-looking information, and is based upon the assumptions and subject to the material risks discussed in our annual and quarterly MD&A. Our actual capital expenditures for future periods may be significantly different.

EXPLORATION
COSTS
($ millions)

 2016 Actual2017 Actual2018 Outlook(2018 Outlook Range)
Exploration Costs4330200

URANIUM AVERAGE UNIT COST OF
SALES - INCLUDING D&A
($CDN/LB)

 2016 Actual2017 Actual2018 Outlook(2018 Outlook Range*)
Uranium Average Unit Cost of Sales - Including D&A40.3935.0438.002.00

2016 Actual 2017 Actual 2018 Outlook* (2018 Outlook Range)

* Based on the expected unit cost of sales for produced material and committed long-term purchases including our JV Inkai purchases. If we make discretionary purchases in 2018, then we expect the overall unit cost of sales may be affected.